Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,756 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,095 products)
- Organic Building Blocks(61,037 products)
Found 196139 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
N-(4-Amino-3-methoxyphenyl)acetamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H12N2O2Purity:Min. 95%Molecular weight:180.2 g/mol(2-chloro-3,4-dimethoxyphenyl)methanol
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H11ClO3Purity:Min. 95%Molecular weight:202.64 g/molHNF4 Antagonist, BI6015
CAS:<p>BI6015 is a fatty acid that inhibits the transcriptional regulation of genes involved in tumorigenesis, cell survival, and drug resistance. It has been shown to inhibit the uptake of glucose and fatty acids by cells. BI6015 also blocks the binding of growth factor-β1 to its receptor, thereby inhibiting signal transduction pathways that regulate cell proliferation and differentiation. BI6015 has been shown to inhibit the activity of enzymes involved in lipid synthesis, which may contribute to its ability to prevent congenital heart disease. This drug has been tested in animal models with promising results but it is not yet known how it will affect human subjects.<br>BI6015 is rapidly absorbed after oral administration and excreted unchanged in urine. The pharmacokinetic properties of this compound have not yet been evaluated in humans.</p>Formula:C15H13N3O4SPurity:Min. 95%Molecular weight:331.35 g/mol2-Amino-N-(2,4-dimethoxyphenyl)benzamide
CAS:<p>Versatile small molecule scaffold</p>Formula:C15H16N2O3Purity:Min. 95%Molecular weight:272.3 g/mol4-[(1-Methylpiperidin-4-yl)oxy]benzoic acid hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H18ClNO3Purity:Min. 95%Molecular weight:271.74 g/molrac-Tetrabenazine
CAS:Controlled Product<p>Tetrabenazine is a drug that is used to treat hyperkinesia, a neurological disorder. It decreases the release of dopamine in the brain by binding to and blocking the activity of vesicular monoamine transporter 2 (VMAT2) and inhibits the reuptake of dopamine into synaptic vesicles. Tetrabenazine has been shown to decrease locomotor activity in rats. The clinical relevance of tetrabenazine is not known, but it may have adverse effects on the liver, for example, if taken with anhydrous sodium. Tetrabenazine is not recommended for use in patients with hepatic impairment or with symptoms of liver disease.</p>Formula:C19H27NO3Purity:Min. 95%Molecular weight:317.42 g/mol3-Methoxy-4-(3-oxopropoxy)benzonitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H11NO3Purity:Min. 95%Molecular weight:205.21 g/mol5-(Oxan-4-yl)-1,3,4-thiadiazol-2-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H11N3OSPurity:Min. 95%Molecular weight:185.25 g/molN1-(4-Methoxypyrimidin-2-yl)benzene-1,4-diamine
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H12N4OPurity:Min. 95%Molecular weight:216.2 g/mol2,6-Dioxaspiro[4.5]decan-9-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H15NO2Purity:Min. 95%Molecular weight:157.21 g/mol4-(5-Ethylfuran-2-carbonyl)aniline
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H13NO2Purity:Min. 95%Molecular weight:215.25 g/mol[2-(2-Phenylethyl)pyrimidin-4-yl]methanol
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H14N2OPurity:Min. 95%Molecular weight:214.26 g/mol4-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C20H21NO4Purity:Min. 95%Molecular weight:339.4 g/mol3-(2-Methyl-1,4-oxazepan-4-yl)propanenitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H16N2OPurity:Min. 95%Molecular weight:168.24 g/mol2-{Cyclopentyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino}acetic acid
CAS:<p>The synthesis of 2-{Cyclopentyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino}acetic acid is accomplished through an asymmetric, stereoselective, catalytic route. The first step in the synthesis is conversion of glycine to the corresponding N-protected glycine methyl ester by reaction with benzyl chloroformate followed by protection of both carboxylic acid groups as FMOC derivatives. The key steps are a diastereoselective hydrogenation of the cyclopentane ring system and an efficient alkylation reaction of the resulting alcohol with 9H-fluoren-9-ol. <br>2-[Cyclopentyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]acetic acid has been shown to be a potent inhibitor against bacterial growth. It binds to bacterial topoisomerase IV enzyme, which</p>Formula:C22H23NO4Purity:Min. 95%Molecular weight:365.4 g/mol4-(But-3-yn-1-yl)-1λ⁶-thiomorpholine-1,1-dione
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H13NO2SPurity:Min. 95%Molecular weight:187.3 g/mol2-(Pyridin-4-yl)oxan-4-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H14N2OPurity:Min. 95%Molecular weight:178.23 g/mol3-[(2-Methylbutan-2-yl)oxy]azetidine
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H17NOPurity:Min. 95%Molecular weight:143.23 g/molEthyl 1,3-dimethyl-1H-1,2,4-triazole-5-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H11N3O2Purity:Min. 95%Molecular weight:169.18 g/mol2-(2,5-Difluorobenzyl)piperidine
CAS:Controlled Product<p>Versatile small molecule scaffold</p>Formula:C12H15F2NPurity:Min. 95%Molecular weight:211.25 g/mol
